MAPT and Alzheimer disease: AD represents a flagship example that has shifted from postmortem confirmation of diagnosis as gold standard to premortem classification that incorporates molecular neuropathological hallmarks of disease such as in vivo measurement of β-amyloid, hyperphosphorylated tau, and TDP-43.